Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis (Q93782407)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

title

Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

1 reference

1 reference

0 references

J M Dickinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

G A Ellard

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

D A Mitchison

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

publication date

1 December 1968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

page(s)

351-366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

Experimental chemotherapy of tuberculosis.

10 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Long-term, two-stage chemotherpay of advanced experimental murine tuberculosis with intermittent regimes during the second stage

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Ocular manifestations of ethambutol, Toxic amblyopia after administration of an experimental antituberculous drug

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Antituberculous drugs (TH 1314 and INH) in the host organism

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

FURTHER EXPERIMENTS ON LONG-TERM CHEMOTHERAPY OF ADVANCED MURINE TUBERCULOSIS, WITH EMPHASIS ON INTERMITTENT REGIMES.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Late results of long-term, intermittent chemotherapy of advanced, murine tuberculosis: Limits of the murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

The ocular toxicity of ethambutol and its relation to dose

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Madras study of supervised once-weekly chemotherapy in the treatment of pulmonary tuberculosis: clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

Central nervous system effects of ethambutol in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0041-3879%2868%2980016-9

7 January 2021

10.1016/S0041-3879(68)80016-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4975543%20AND%20SRC:MED&resulttype=core&format=json

10 May 2020

1 reference